Triterpenic Acid Amides as a Promising Agent for Treatment of Metabolic Syndrome
Autor: | Vladislav Fomenko, Mikhail Blokhin, Sergey Kuranov, Mikhail Khvostov, Dmitriy Baev, Marina S. Borisova, Olga Luzina, Tatyana G. Tolstikova, Nariman F. Salakhutdinov |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Scientia Pharmaceutica, Vol 89, Iss 1, p 4 (2020) |
Druh dokumentu: | article |
ISSN: | 2218-0532 0036-8709 |
DOI: | 10.3390/scipharm89010004 |
Popis: | A series of triterpenic acid amides were synthesized incorporating a 2-ethoxy-3-phenylpropanoic acid pharmacophore fragment. The synthesized compounds were tested for their ability to improve glycemic control and to counter lipid abnormalities in C57BL/6 mice placed on a high-fat/high-cholesterol diet. Of all tested compounds, the dihydrobetulonic derivative (16b) had the most pronounced effect in decreasing blood glucose levels, total cholesterol (TC), and high-density lipoproteins (HDL). All the synthesized compounds displayed a relatively safe profile in the animal studies carried out in this work. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |